Clinical trial
Phase I Study of Iressa and CRT/IMRT in Chinese Patients With IIIB/IV NSCLC…
NCT00497250 · Fudan University, Other · Unknown status
Key facts
| NCT number | NCT00497250 |
|---|---|
| Title | Phase I Study of Iressa and CRT/IMRT in Chinese Patients With IIIB/IV NSCLC After Failure of Platinum-Based Chemotherapy |
| Official title | Phase I Study of Iressa and CRT/IMRT in Chinese Patients With IIIB/IV NSCLC After Failure of Platinum-Based Chemotherapy |
| Lead sponsor | Fudan University, Other |
| Status | Unknown status |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Carcinoma, Non-Small-Cell Lung |
| Intervention type | Device, Drug |
| Interventions | Gefitinib, Radiation Therapy |
| Enrollment | 32 |
| Start date | Jul 1, 2007 |
| Primary completion | Mar 1, 2009 |
| Completion | Oct 1, 2009 |
| First posted | Jul 6, 2007 |
| Last update posted | Oct 21, 2008 |
| Countries | China |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: